Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rang in Aktien #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aktienkurs
$59.98
Zuletzt synchronisiert: 2024-12-13
Marktkapitalisierung
$1.22B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategorie

Healthcare
EPS für Longboard Pharmaceuticals, Inc. (LBPH)
EPS zum September 2024 TTM: $-2.24
Laut den aktuellen Finanzberichten und dem Aktienkurs von Longboard Pharmaceuticals, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $-2.24. Am Ende des Jahres 2022 betrug das EPS $-2.51 eine Steigerung gegenüber dem EPS von 2021, das $-1.62 betrug.
EPS-Verlauf von Longboard Pharmaceuticals, Inc. von 2020 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -873.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,338.39%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 136.16%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 256.25%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH